Popular Articles

Exporters want stimulus to continue
With an expected rise in the key lending rates the government should continue with the stimulus measures to support exporters, an industry body said today.

Aditi sharpens focus on services; to double headcount
Aditi Technologies, an outsourced product and application development firm, is increasing its focus on intellectual property (IP)-led domain services for which it plans to double its headcount to over 2,000 people over the next 18 months. The company hopes this move will help it cross the $120 million mark in revenues during the same period.

News of the day

Apollo Tyres net, sales surge
Apollo Tyres, India’s second largest tyre manufacturer by tonnage, posted an 18-fold increase in net profit at Rs 102 crore for the quarter ended December 31, as compared to Rs 5.5 crore in the same quarter a year earlier.
Home Business

Natco Pharma FY09 net rises 8.5% at Rs 44 cr

Hyderabad-based drug maker Natco Pharma reported an 8.5 per cent rise in its consolidated net profit at Rs 43.98 crore for the year ended March 2009, compared with Rs 40.52 crore posted in the previous year. - Lupin buys worldwide rights for nasal spray AllerNaze - Glenmark"s diabetes drug to enter phase lll trials - Emami realty arm to be listed on BSE in 3-4 months - Piramal Healthcare gets nod for appt of Nandini Piramal as ED - Sun Pharma gets USFDA nod for anti hypertensive drug - Step up vigil to stop fake Made-in-India drugs in Africa: govt Revenues were up to Rs 465 crore from Rs 364 crore in the same period, registering a growth of 28 per cent. The company stated that the growth in profit was lower on account of expenses on Phase I clinical trials of its new chemical entity with multiple oncological indications.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):